CTMX

2.0300.98%
MP

Marcia P. Belvin

Senior VP & Chief Scientific Officer

Dr. Marcia P. Belvin, Ph.D., is Member of Scientific Advisory Board of Noetik Inc. from October 2025. Dr. Belvin serves as Chief Scientific Officer CytomX Therapeutics, Inc. since 2023 and serves as its Senior Vice President since October 2020. She served as Head of Research at CytomX Therapeutics, Inc. since October 2020 until 2023 and served as its Vice President of Oncology Research until October 2020. Dr. Belvin joined CytomX in 2018, with industry experience in oncology research and drug discovery to the company. Prior to CytomX, Dr. Belvin held roles of increasing responsibility at Genentech where, over 13 years, she led multiple preclinical pipeline teams and oversaw programs in cancer signaling, cancer metabolism and cancer immunology. Dr. Belvin began her career at Exelixis where she managed teams responsible for preclinical pipeline discovery within the oncology and inflammation portfolios. Dr. Belvin received her B.A. degree from Harvard University and her Ph.D. from the University of California, Berkeley. Dr. Belvin also trained at the Dana-Farber Cancer Institute and the Cold Spring Harbor Laboratory.

Positions